• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “accent-therapeutics” Archives

          in
          Entry Author Date Location
          Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins Sarah de Crescenzo 06/04/20 Boston
          Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More Frank Vinluan 04/24/20 National
          Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone Frank Vinluan 09/06/19 National
          It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help Frank Vinluan 04/18/19 Boston
          Ribometrix Takes Aim at “Undruggable” RNA with $30M Series A Funding Corie Lok 11/13/18 Raleigh Durham
          In New York, Gotham Starts Up With $54M for RNA-Modifying Drugs Corie Lok 10/10/18 New York
          Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout Alex Lash 05/18/18 National
          Accent Therapeutics Debuts With $40M To Target RNA Modification Corie Lok 05/18/18 Boston
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Biotech Startups: How to Succeed in a COVID-19 World

            Xconomy Insight · Special Report

            Biotech Startups: How to Succeed in a COVID-19 World

            Industry experts explain what it takes to launch a new biotech company

          • The Bay Area and Beyond: Biocom Talks Innovation and COVID

            Sponsored · Video

            The Bay Area and Beyond: Biocom Talks Innovation and COVID

            A Fireside Chat with Biocom President & CEO Joe Panetta

            Biocom
          • Fish & Richardson: Patent Law in Regards to AI and Machine Learning

            Sponsored · Video

            Fish & Richardson: Patent Law in Regards to AI and Machine Learning

            A Fireside Chat with Fish & Richardson Principal Teresa Lavoie

            Fish & Richardson

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.